Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 01 08 2022
revised: 09 10 2022
accepted: 21 10 2022
pubmed: 30 10 2022
medline: 15 12 2022
entrez: 29 10 2022
Statut: ppublish

Résumé

Syncopal events in patients with hypertrophic cardiomyopathy (HCM) are of concern as they are a vital consideration in algorithms for risk stratification for sudden cardiac death (SCD) and ICD implantation. However, the cause of syncope is often under-investigated and/or unexplained. Current syncope guidelines do not provide a detailed definition of unexplained syncope. To address this important gap, an international panel of experts in the field of both syncope and HCM wrote a consensus document with the aim of providing practical guidance for the diagnosis and management of syncope in patients with HCM.

Identifiants

pubmed: 36309161
pii: S0167-5273(22)01664-3
doi: 10.1016/j.ijcard.2022.10.153
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

330-337

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Michele Brignole (M)

IRCCS Istituto Auxologico Italiano, Dept of Cardiology, Hospital S. Luca, Milan, Italy. Electronic address: mbrignole@outlook.it.

Franco Cecchi (F)

IRCCS Istituto Auxologico Italiano, Dept of Cardiology, Hospital S. Luca, Milan, Italy.

Aris Anastasakis (A)

Unit of Inherited and Rare Cardiovascular Diseases, Onassis Cardiac Surgery Centre, Kallithea, Greece.

Lia Crotti (L)

IRCCS Istituto Auxologico Italiano, Dept of Cardiology, Hospital S. Luca, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. Electronic address: l.crotti@auxologico.it.

Jean Claude Deharo (JC)

Hôpitaux de Marseille, Centre Hospitalier Universitaire La Timone, Service de Cardiologie, Marseille, France; Aix Marseille Université, C2VN, Marseille, France. Electronic address: jeanclaude.deharo@ap-hm.fr.

Perry M Elliott (PM)

Institute of Cardiological Sciences, University College London, UK. Electronic address: perry.elliott@ucl.ac.uk.

Artur Fedorowski (A)

Dept. of Cardiology, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden. Electronic address: artur.fedorowski@ki.se.

Juan Pablo Kaski (JP)

Institute of Cardiovascular Science, University College London and Great Ormond Street Hospital, London, UK. Electronic address: j.kaski@ucl.ac.uk.

Giuseppe Limongelli (G)

Department of Translational Medical Sciences, University of Campania "Luigi VanvitellI", AO Dei Colli-Monaldi Hospital, Naples, Italy.

Martin S Maron (MS)

HCM Center, Lahey Hospital and Medical Center, Burlington, MA, USA. Electronic address: mmaron@tuftsmedicalcenter.org.

Iacopo Olivotto (I)

Meyer Children Hospital, Department of Experimental and Clinical Medicine, University of Florence, Italy. Electronic address: iacopo.olivotto@unifi.it.

Steve R Ommen (SR)

Medicine, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. Electronic address: ommen.steve@mayo.edu.

Gianfranco Parati (G)

IRCCS Istituto Auxologico Italiano, Dept of Cardiology, University of Milano Bicocca, Milan, Italy. Electronic address: gianfranco.parati@unimib.it.

Win Shen (W)

Mayo Clinic Arizona, Phoenix, AZ, USA. Electronic address: wshen@mayo.edu.

Andrea Ungar (A)

Division of Geriatric and Intensive Care Medicine, Azienda Ospedaliero Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence andFlorence, Italy. Electronic address: andrea.ungar@unifi.it.

Arthur Wilde (A)

Heart Centre, Department of Cardiology, Amsterdam Universitair Medische Centra, Amsterdam,location AMC, the Netherlands. Electronic address: a.a.wilde@amsterdamumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH